Tepotinib-induced interstitial lung disease in a patient with adenosquamous lung carcinoma

We report a case of drug-induced lung injury in an 88-year-old man with non-small cell lung cancer harboring an MET exon 14 skipping mutation. The patient developed dyspnea and new ground-glass opacities shortly after the initiation of tepotinib, an oral MET-tyrosine kinase inhibitor (MET-TKI). Clin...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Takeshi Imakura, Soji Kakiuchi, Ikumi Nishimura, Naoya Murakami, Hiroki Yamamoto, Hitomi Kagawa, Mami Inayama, Takashi Haku
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2026-01-01
Цуврал:	Respiratory Medicine Case Reports
Нөхцлүүд:	MET-TKI Tepotinib ILD Lung cancer
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2213007125001911
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!